Toronto-based Cultivar Holdings has launched a new tested artificial intelligence technology (“PredictMedix”) that it says will revolutionize how companies and law enforcement are able to test sobriety by detecting impairment for alcohol and cannabis. The company recently went public and its shares began trading on the Canadian Securities Exchange (CSE:CULT).
Shares have already seen a spike as the word gets out about Cultivar Holdings’ PredictMedix technology, as well as other business endeavors focused on cannabis that includes low cost grow operations in Jamaica.
